Chemcon Speciality Chemicals Ltd
Chemcon Speciality Chemicals Ltd Q3 FY26 Results & Presentation Highlights: Revenue ₹57.3 Cr, PAT ₹5.1 Cr
Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemcon Speciality Chemicals Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q3 FY26 Revenue from Operations: ₹57.3 Cr (vs ₹54.4 Cr in Q3 FY25) — approx. Q3 FY26 EBITDA: ₹6.7 Cr, down from ₹11.3 Cr in Q3 FY25 (year-on-year decline) - Q3 FY26 PAT: ₹5.1 Cr, down from ₹8.8 Cr in Q3 FY25 (year-on-year decline) - Revenue from operations for Q3 FY26: ₹57.3 Cr vs ₹54.4 Cr in Q3 FY25 (year-on-year increase) - Operating margin (EBITDA margin) for Q3 FY26 approx.
From Chemcon Speciality Chemicals Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
2 more points management made on revenue & sales performance
Profitability & Margins
See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capacity expansion with two new units: P-10 and P-11, both to manufacture organic chemicals (Page 21, 19).
- Proposed P-10 and P-11 units expected to be operational by Q4 FY26 (Page 19).
- Acquisition of Shivam Petrochem Industries to enhance product portfolio via slump sale for ₹36 crore (Page 8).
- No explicit capex amounts stated for P-10 and P-11 units individually, only timelines and planned use.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemcon Speciality Chemicals Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q1 FY22 earnings call →
- Q4 FY21 earnings call →
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q3 FY26)
Revenue from Operations for Q3FY26: ₹331.30 crore, compared to ₹320.59 crore in Q3FY25 (consolidated) and ₹304.68 crore in Q3FY25 (standalone). Key investor pre
- Vidhi Specialty Food Ingredients Ltd (Q3 FY26)
94.5 Cr, down 4.1% YoY from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY26 investor presentation — and how it ranks
- Bodal Chemicals Ltd (Q3 FY26)
5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. Key investor presentation takeaways from Bodal Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks against s
- Valiant Organics Ltd (Q3 FY26)
Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn) . Key investor presentation takeaways from Valiant Organics L
Frequently Asked Questions
What were Chemcon Speciality Chemicals Ltd Q3 FY26 results?
Q3 FY26 Revenue from Operations: ₹57.3 Cr (vs ₹54.4 Cr in Q3 FY25) — approx. Q3 FY26 EBITDA: ₹6.7 Cr, down from ₹11.3 Cr in Q3 FY25 (year-on-year decline) - Q3 FY26 PAT: ₹5.1 Cr, down from ₹8.8 Cr in Q3 FY25 (year-on-year decline) - Revenue from operations for Q3 FY26: ₹57.3 Cr vs ₹54.4 Cr in Q3 FY25 (year-on-year increase) - Operating margin (EBITDA margin) for Q3 FY26 approx.
What is Chemcon Speciality Chemicals Ltd share price analysis?
Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemcon Speciality Chemicals Ltd planning capital expenditure?
Planned capacity expansion with two new units: P-10 and P-11, both to manufacture organic chemicals (Page 21, 19).
Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.